Approval · Notice of Compliance 6221 · 2005
VELCADE: Notice of Compliance 6221
Issued January 27, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 6221
- Date
- January 27, 2005
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antineoplastic agent
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VELCADE | 02262452 | Marketed |
Medicinal ingredients
- BORTEZOMIB MANNITOL BORONIC ESTER 3.5 MG per VIAL